The most common male sexual disorder\[1-2\] is premature ejaculation (PE), also referred to as early ejaculation (EE) or rapid ejaculation (RE), and affects 30%-40% of sexually active men, ([@CIT0001]--[@CIT0003]) perhaps as many as 75% of men at some points in their lives.([@CIT0004]) PE has been defined as uncontrolled ejaculation with the essential feature of recurrent or persistent orgasm with minimal sexual stimulation before, on, or after penetration and before the person desires it.([@CIT0005])

Different treatment approaches have been used for the treatment of PE including local anaesthetic sprays, propranolol and serotonin reuptake inhibitors ([@CIT0006]--[@CIT0009]).

Despite the increasing availability of effective conventional medical treatments, plant-derived and herbal remedies continue to provide a popular alternative for men and women seeking to improve their sex life ([@CIT0010]). The benefits of herbal and other natural products (dietary supplements) are increasingly cited in the media ([@CIT0011]). Traditional Chinese Medicine(TCM) which evolved out of the physiology and health, was a reflection of the processes observed in natural health. Herbal formulas constitute an important aspect of TCM treatment. However, understanding how herbs interact with one another in the context of complex herbal formulation is unclear from the western scientific perspective.([@CIT0012]) Nevertheless, the efficacy of most herbal agents in treating sexual problems remains uncertain. Therapists and consumers alike would benefit from an increased understanding of commonly used herbal agents on the market, their purported or supported effects, and their potential side effects ([@CIT0010]). VigRX is a sexual complementary which containing aphrodisiac herbal concentrates from China, Europe and South America that stimulate sexual activity. VigRX ingredients includes: Epimedium Leaf Extract \[20:1\] 15mg, Cuscuta Seed Extract \[4:1\] 25mg, Ginkgo Biloba Leaf 100mg, Asian Ginseng Root 100mg, Saw Palmetto Berry-Fructus Serenoae 100mg, Muira Pauma Bark Extract \[4:1\] 50mg, Catuaba Bark Extract \[4:1\] 50mg, Hawthorn Berry-Fructus Crataegi 100mg. VigRX is recommended for various sexual dysfunctions including PE([@CIT0013], [@CIT0014]) We conducted a double-blind, placebo-controlled study to determine the efficacy and probable side effects of this supplement on PE.

Materials and Method {#S0005}
====================

This is a randomized double blind fixed dose study which conducted in Roozbeh Psychiatry Hospital in Tehran University of Medical Sciences (TUMS) during July 2007 to March 2009. Ninety nine married male patients were studied. They applied to TUMS Departments of Psychiatry and Urology and were diagnosed with primary PE according to DSM-IV-TR. ([@CIT0005]). After complete description of the study to the volunteers, the written informed consent including necessary details of the study was obtained from each patient. Each patient underwent a diagnostic evaluation by one trained psychiatrist using Structured Clinical Interview for DSM-IV-TR. To exclude organic sexual dysfunctions, each patient was evaluated by researchers. Exclusion criteria were as follows: the presence of erectile dysfunction and inhibited male orgasm, a severe physical or mental illness, the history of alcohol and any substance abuse or dependence. The patients were randomly assigned in two groups: group 1 consisting of 48 patients, and group 2 consisting of 51 patients in a double-blind design. In group 1, the patients received one placebo capsule; and the patients in group 2 received one capsule (540mg) of vigRX for a four week treatment course. The use of concomitant medications was prohibited. The intravaginal ejaculation latency time (IELT) was defined as the duration between vaginal intromission and ejaculation.All of the subjects were asked to determine the intravaginal ejaculation latency time before initiating and after the 4-week -treatment period via a chronometer. The patients and their wives were encouraged to engage in coitus at least twice a week and record intravaginal ejaculation latency time. All patients and their partners were individually interviewed at the beginning of the study and at the end of the treatment period.

All the patients were asked to complete the Chinese Index of Premature Ejaculation (CIPE)([@CIT0015]) questionnaire before and after the treatment period. Statistical analysis has done by using SPSS software (15^th^ version). Independent sample T-test was performed in order to analyzing our data.

Results {#S0006}
=======

Fourteen patients dropped out of the study during the presence of any endocrinological state or taking any psychotropic medications within the last 2 weeks prior to the study. All the patients were heterosexual. The patients who completed the treatment course, 42 patients were in group 1 (placebo), and 43 in group 2 (vigRX). The mean age, mean IELT and mean CIPE score in both groups were obtained. The baseline data were compared in the two groups and was not statistically significant ([Table 1](#T0001){ref-type="table"}).

###### 

Baseline data of patients

  Variable              Group 1     Group 2     Pvalue
  --------------------- ----------- ----------- --------------------------------------
  Mean age (years)      27.0±5.7    25.9±3.4    NS[\*](#TF0001){ref-type="table-fn"}
  Mean IELT (seconds)   72.6±68.9   70.8±55.5   NS
  Mean CIPE score       27.1±8.0    27.0±5.6    NS

NS=Non Significant

The mean IELT was 95.1±72.8 seconds and 102.8±66.2 seconds in group 1 and 2 respectively at the end of the treatment course. The mean IELT increased after the 4- week treatment in both groups but it increased more in group 2. The mean IELT differences between the two groups was not statistically significant. ([Table 2](#T0002){ref-type="table"}).

###### 

Comparison of intravaginal ejaculation latency time (IELT) score between two groups

  group        mean IELT before treatment (seconds)   mean IELT after treatment (seconds)   mean IELT difference (seconds)   df   t     Pvalue
  ------------ -------------------------------------- ------------------------------------- -------------------------------- ---- ----- --------------------------------------
  1(Placebo)   72.6±68.9                              95.1±72.8                             22.4±36.2                        83   1.2   NS[\*](#TF0002){ref-type="table-fn"}
  2(vigRX)     70.8±55.5                              102.8±66.2                            32.0±36.5                                   

NS=Non Significant

The mean CIPE score increased 2.4±5.0 and 4.3±4.1 in group 1 and 2 respectively. CIPE score increased after the 4- week -treatment in both groups but more in group 2. The mean CIPE score differences between the two groups was not statistically significant ([Table 3](#T0003){ref-type="table"}).

###### 

Comparison of Index of Premature Ejaculation (CIPE) score between two groups

  group         mean CIPE score before treatment   mean CIPE score after treatment   mean CIPE difference   df   t       Pvalue
  ------------- ---------------------------------- --------------------------------- ---------------------- ---- ------- --------------------------------------
  1( Placebo)   27.1±8.0                           29.5±6.7                          2.4±5.0                83   0.162   NS[\*](#TF0003){ref-type="table-fn"}
  2(vigRX)      27.0±5.6                           31.4±6.3                          4.3±4.1                             

NS=Non Significant

No side effect was reported by the subjects in both groups during the treatment course.

Discussion {#S0007}
==========

In this study, we examined the efficacy of vigRX as a sexual complementary herbal drug which contains eight herbal supplements including: Epimedium Leaf Extract, Cuscuta Seed Extract, Ginko Biloba Leaf, Asian Red Ginseng-Panax Ginseng, Saw Palmetto Berry, Muira Pauma Bark Extract, Catuaba Bark Extract and Hawthorn Berry in the treatment of primary PE.

Although patients who received vigRX showed more improvement in IELT and CIPE scores compared with those who received placebo, the differences between the two groups was not statistically significant. On the other hand increasing of IELT and CIPE score in the placebo group may indicating placebo effects in patients who were studied. No side effect was seen in the patients in both groups during the treatment course.

In an open trial study was done by Cohen et al ginkgo biloba was found to be 84% effective in treating antidepressant-induced sexual dysfunction predominantly caused by selective serotonin reuptake inhibitors([@CIT0016]).

In a triple--blind randomized, placebo-controlled,clinical trial of ginkgo biloba carried out by Wheathly although some spectacular individual responses was seen but there was no statistically significances in sexual improvement and side effects between two groups([@CIT0017]).

Waynberg et al assessed the efficacy of a unique herbal formulation of Muira puama and Ginkgo biloba (Herbal vX) in 202 healthy women complaining of low sex drive. Responses showed significantly higher average total scores from baseline in 65% of the sample after using the supplement. Statistically significant improvements occurred in frequency of sexual desires, sexual intercourse, and sexual fantasies, as well as in satisfaction with sex life, intensity of sexual desires, excitement of fantasies, ability to reach orgasm, and intensity of orgasm ([@CIT0018]).

Different and sometimes controversial results which reported in the literatures about herbal formulations may be due to the designing and methodology of the studies or individual differences in responding to these supplements.

Using of minimal recommended dosage, small sample size and short treatment course was the main limitations of our study so we recommended future studies with higher vigRX doses, greater sample size and longer treatment courses to further evaluation of the efficacy and probable side effects of this herbal supplement.

This study was done by a grant from Agahan group.
